BUDA, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.798
AS - Asia 840
EU - Europa 527
SA - Sud America 258
AF - Africa 238
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 11
Totale 3.705
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.676
SG - Singapore 322
BR - Brasile 191
CN - Cina 129
HK - Hong Kong 116
DE - Germania 63
FI - Finlandia 46
IT - Italia 45
PL - Polonia 41
RU - Federazione Russa 36
VN - Vietnam 36
FR - Francia 30
GB - Regno Unito 24
SE - Svezia 21
AT - Austria 16
AR - Argentina 15
IN - India 15
TR - Turchia 13
JP - Giappone 12
MU - Mauritius 12
NL - Olanda 12
TT - Trinidad e Tobago 12
UZ - Uzbekistan 12
BY - Bielorussia 11
LB - Libano 11
ME - Montenegro 11
PA - Panama 11
RS - Serbia 11
UA - Ucraina 11
AO - Angola 10
CH - Svizzera 10
DZ - Algeria 10
EC - Ecuador 10
IQ - Iraq 10
KE - Kenya 10
MN - Mongolia 10
AE - Emirati Arabi Uniti 9
ID - Indonesia 9
IE - Irlanda 9
ML - Mali 9
MX - Messico 9
PT - Portogallo 9
TZ - Tanzania 9
UY - Uruguay 9
ZA - Sudafrica 9
BZ - Belize 8
CZ - Repubblica Ceca 8
GH - Ghana 8
HR - Croazia 8
LV - Lettonia 8
MA - Marocco 8
MK - Macedonia 8
NC - Nuova Caledonia 8
SY - Repubblica araba siriana 8
TN - Tunisia 8
TW - Taiwan 8
AU - Australia 7
AZ - Azerbaigian 7
BB - Barbados 7
CM - Camerun 7
EG - Egitto 7
ES - Italia 7
ET - Etiopia 7
JO - Giordania 7
LA - Repubblica Popolare Democratica del Laos 7
LC - Santa Lucia 7
LU - Lussemburgo 7
PE - Perù 7
PF - Polinesia Francese 7
SK - Slovacchia (Repubblica Slovacca) 7
UG - Uganda 7
ZW - Zimbabwe 7
AD - Andorra 6
AF - Afghanistan, Repubblica islamica di 6
AL - Albania 6
CA - Canada 6
CD - Congo 6
CY - Cipro 6
DO - Repubblica Dominicana 6
EE - Estonia 6
GP - Guadalupe 6
HT - Haiti 6
HU - Ungheria 6
LY - Libia 6
NO - Norvegia 6
NP - Nepal 6
PH - Filippine 6
PR - Porto Rico 6
PS - Palestinian Territory 6
SD - Sudan 6
SN - Senegal 6
TJ - Tagikistan 6
XK - ???statistics.table.value.countryCode.XK??? 6
BA - Bosnia-Erzegovina 5
BO - Bolivia 5
BW - Botswana 5
DK - Danimarca 5
GA - Gabon 5
GM - Gambi 5
GR - Grecia 5
Totale 3.473
Salva come PNG Salva come JPEG
Città #
Fairfield 212
Singapore 197
Chandler 164
Ashburn 153
Houston 133
Woodbridge 118
Hong Kong 111
Cambridge 76
Ann Arbor 65
Santa Clara 65
Seattle 62
Wilmington 55
Beijing 48
Boardman 39
Bytom 34
Princeton 30
Los Angeles 29
Munich 26
Medford 24
San Diego 22
Des Moines 21
Chicago 19
Helsinki 19
Ho Chi Minh City 19
Jacksonville 16
New York 16
Roxbury 15
São Paulo 15
Padova 14
Tashkent 12
Panama City 10
Podgorica 10
Ulan Bator 10
Bamako 9
Brooklyn 9
Vienna 9
Belgrade 8
Buffalo 8
Dublin 8
Lappeenranta 8
London 8
Luanda 8
Minsk 8
Nairobi 8
Noumea 8
Nuremberg 8
Rio de Janeiro 8
Turku 8
Accra 7
Amman 7
Bridgetown 7
Castries 7
Kampala 7
Nanjing 7
Papeete 7
Riga 7
Andorra la Vella 6
Baku 6
Dakar 6
Dar es Salaam 6
Dushanbe 6
Harare 6
Kinshasa 6
Luxembourg 6
Montevideo 6
Redondo Beach 6
Vientiane 6
Zagreb 6
Baghdad 5
Belize City 5
Buenos Aires 5
Cotia 5
Hefei 5
Les Abymes 5
Libreville 5
Lusaka 5
Managua 5
Port Louis 5
Port of Spain 5
Pristina 5
Salt Lake City 5
Tallinn 5
Tampa 5
Tunis 5
Abidjan 4
Addis Ababa 4
Algiers 4
Athens 4
Banjul 4
Belo Horizonte 4
Bishkek 4
Boston 4
Brazzaville 4
Budapest 4
Cape Town 4
Cotonou 4
Dallas 4
Dubai 4
Guangzhou 4
Hanoi 4
Totale 2.254
Salva come PNG Salva come JPEG
Nome #
Phytosome complex of curcumin as complementary therapy of advanced pancreatic cancer improves safety and efficacy of gemcitabine: Results of a prospective phase II trial 237
Detection of a fluorescent-labeled avidin-nucleic acid nanoassembly by confocal laser endomicroscopy in the microvasculature of chronically inflamed intestinal mucosa 208
MiR-155 modulates the inflammatory phenotype of intestinal myofibroblasts by targeting SOCS1 in ulcerative colitis 196
Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease 175
TAK1 is a key modulator of the profibrogenic phenotype of human ileal myofibroblasts in Crohn’s disease 170
Increased risk of NASH in patients carrying the C(-159)T polymorphism in the CD14 gene promoter region 160
A propensity score-weighted comparison between adalimumab originator and its biosimilars, ABP501 and SB5, in inflammatory bowel disease: a multicenter Italian study 150
Semiautomatic evaluation of crypt architecture and vessel morphology in confocal microendoscopy: Application to ulcerative colitis 143
Biliary Tree Diagnostics: Advances in Endoscopic Imaging andand Tissue Sampling 136
Intestinal Surgery for Crohn's Disease: Predictors of Recovery, Complications and Health Related Quality of Life 127
Expression in ileal mucosa and sub-epitelial myofibroblasts is correlated to a pro-fibrogenetic phenotype in patients with Crohn's disease 121
Dual Targeted Therapy: a possible option for the management of refractory Inflammatory Bowel Disease 120
Reply to comment: Screening for active COVID-19 infection prior to biologic therapy in IBD patients: primum non nŏcēre 116
Rapid point-of-care anti-infliximab antibodies detection in clinical practice: comparison with ELISA and potential for improving therapeutic drug monitoring in IBD patients 115
Effects of SARS-CoV-2 emergency measures on high-risk lesions detection: a multicentre cross-sectional study 112
Reply to comment: Asymptomatic screening for SARS COV-2 prior to commencement of biologic therapies in patients with inflammatory bowel disease - a potentially harmful practice 108
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care 107
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study 103
TAK1 Expression in Ileal Mucosa and Sub-Epithelial Myofibroblasts Is Correlated to a Pro-Fibrogenic Phenotype in Patients with Crohn's Disease 102
The role of wireless capsule endoscopy (WCE) in the detection of occult primary neuroendocrine tumors 98
Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results from the SoCOVID-19 Survey 97
Increased intestinal permeability in obese mice: new evidences in the pathogenesis of nonalcoholic steatohepatitis. 96
Starting a biologic therapy in IBD patients amidst COVID-19: hold, careful monitoring or testing? 95
Lymphoproliferative disorders in heart transplant recipients: role of hepatitis C virus (HCV) and Epstein-Barr (EBV) infection 88
Should Patients With Inflammatory Bowel Disease Be Tested for Active COVID-19 Before Starting a Biological Treatment? 88
Toward a potential association between eosinophilic esophagitis and Klinefelter syndrome: a case series and review of the literature 86
Reply Letter to “Oral butyrate modulates the gut microbiota in patients with inflammatory bowel disease, most likely by reversing proinflammatory metabolic reprogramming of colonocytes” 83
Chicago classification v4.0 protocol improves specificity and accuracy of diagnosis of oesophagogastric junction outflow obstruction 82
Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD clinical guidelines based on the GRADE methodology 76
Eosinophilic Esophagitis and Achalasia: Are We Putting All the Pieces Together? 76
Hereditary Colorectal Cancer Syndromes and Inflammatory Bowel Diseases: an ECCO CONFER Multicenter Case Series 71
Totale 3.742
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.582
article - articoli 13.132
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.714
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021202 0 0 0 0 33 21 12 15 32 33 35 21
2021/2022404 21 50 32 28 42 22 16 41 26 12 41 73
2022/2023291 55 43 8 29 47 35 2 23 29 4 12 4
2023/2024176 4 30 31 17 8 23 13 2 10 4 20 14
2024/2025724 0 48 32 23 94 19 27 61 67 34 134 185
2025/20261.443 159 294 470 495 25 0 0 0 0 0 0 0
Totale 3.742